TRDA 8-K 2026-11-05

Entrada Therapeutics, Inc. (TRDA) 8-K dated 2026-11-05 — accession 0001689375-26-000063.

Entrada Therapeutics, Inc. (TRDA) is a biotechnology company listed on US.

Entrada Therapeutics, Inc. filed a 8-K on 2026-11-05. Accession 0001689375-26-000063.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported TRDA revenue for 2025-12-31 was $25.4M. Net income was -$143.8M. Revenue was down 87.9% from 2024-12-31 to 2025-12-31. TRDA currently screens at market cap $274.4M.

Not investment advice. The TRDA SEC hub lists recent forms. The stock page is the research view.